Our result showed that CTLA-4 knockdown in CRC cell lysate-loaded DCs enhances autologous T cell activation and cytokine secretion, implying a promising therapeutic option for future preclinical and clinical investigations (Figure 6). This evidence concerns the gene CTLA4 and colorectal carcinoma.